data_1sp0_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1sp0 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.9 p . . . . . 0 CA--C 1.533 0.293 0 N-CA-C 108.282 -1.007 . . . . 10.0 108.282 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 40.78 43.6 1.71 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.754 1.622 . . . . 10.0 111.395 -167.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 173.45 159.29 0.13 Allowed 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 131.235 3.814 . . . . 10.0 103.821 -177.199 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -157.22 24.03 0.3 Allowed 'General case' 0 C--O 1.22 -0.463 0 CA-C-N 119.021 0.828 . . . . 10.0 112.996 -166.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 45.9 m -75.65 3.7 9.15 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 121.034 1.743 . . . . 10.0 114.323 -169.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -77.25 -37.45 53.07 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.633 1.173 . . . . 10.0 108.892 161.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 46.6 mt -106.52 -8.71 16.93 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 127.759 2.424 . . . . 10.0 113.972 -171.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 92.0 mt -69.28 81.21 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 120.172 1.351 . . . . 10.0 109.214 172.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -89.29 176.05 7.1 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 107.354 -1.35 . . . . 10.0 107.354 162.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -76.44 -18.87 58.58 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 115.655 1.724 . . . . 10.0 115.655 -154.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -51.45 102.4 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 119.699 1.136 . . . . 10.0 112.763 -176.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 46.3 tttp -76.95 86.02 3.49 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 106.139 -1.801 . . . . 10.0 106.139 173.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -95.25 124.95 48.02 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.675 0 N-CA-C 108.261 -1.015 . . . . 10.0 108.261 -166.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 4.9 tmtt? -78.2 147.52 34.42 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.388 1.075 . . . . 10.0 108.869 -174.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 38.8 t -137.36 147.37 26.7 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.574 0 N-CA-C 107.247 -1.39 . . . . 10.0 107.247 177.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 86.4 m -132.75 95.4 3.58 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 125.114 1.366 . . . . 10.0 107.579 -166.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -78.83 97.06 5.81 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 124.244 1.018 . . . . 10.0 109.147 -176.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -85.47 84.24 7.69 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 121.708 0.766 . . . . 10.0 109.66 -173.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -79.66 127.91 32.75 Favored 'General case' 0 CA--C 1.533 0.32 0 O-C-N 121.661 -0.649 . . . . 10.0 110.716 173.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -132.44 154.96 49.35 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 125.123 1.369 . . . . 10.0 109.071 175.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.7 p -147.95 149.43 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 C-N-CA 124.311 1.044 . . . . 10.0 109.326 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -148.22 175.17 11.28 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 125.074 1.35 . . . . 10.0 108.606 174.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -33.49 -52.51 0.39 Allowed 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 126.582 1.953 . . . . 10.0 113.711 -176.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -47.47 -27.57 4.29 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 125.235 1.398 . . . . 10.0 114.554 -178.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.45 ' CD2' ' CD2' ' A' ' 47' ' ' TRP . 0.6 OUTLIER -126.91 96.84 33.83 Favored Pre-proline 0 CA--C 1.531 0.249 0 CA-C-N 118.953 1.376 . . . . 10.0 108.829 166.11 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -81.14 44.97 1.86 Allowed 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 123.627 2.884 . . . . 10.0 110.096 -175.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.45 ' CD2' ' CD2' ' A' ' 45' ' ' LEU . 44.1 m0 -114.82 141.89 47.28 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.332 1.053 . . . . 10.0 108.325 -172.027 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -77.49 80.61 3.97 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 106.415 -1.698 . . . . 10.0 106.415 -178.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -82.34 89.18 6.55 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 108.372 -0.973 . . . . 10.0 108.372 -175.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.6 m -84.81 126.9 67.11 Favored Pre-proline 0 CA--C 1.534 0.361 0 N-CA-C 109.401 -0.592 . . . . 10.0 109.401 -175.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -70.71 153.59 64.46 Favored 'Trans proline' 0 N--CA 1.448 -1.162 0 N-CA-C 107.659 -1.708 . . . . 10.0 107.659 158.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -78.96 -52.41 15.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 121.35 0.595 . . . . 10.0 109.726 178.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -131.14 159.57 37.27 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 104.696 -2.335 . . . . 10.0 104.696 164.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 32.0 tpt180 -58.99 -39.71 82.66 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 109.022 -0.733 . . . . 10.0 109.022 169.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.9 p30 -150.79 165.49 33.39 Favored 'General case' 0 N--CA 1.437 -1.102 0 C-N-CA 125.143 1.377 . . . . 10.0 110.718 -163.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 46.6 pt -144.63 179.33 1.33 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.178 0 C-N-CA 126.91 2.084 . . . . 10.0 107.788 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -128.52 158.69 37.7 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 108.924 -0.769 . . . . 10.0 108.924 150.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 34.6 m -133.76 141.44 44.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 C-N-CA 126.096 1.759 . . . . 10.0 107.645 173.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 5.5 mmm-85 -75.07 91.41 2.55 Favored 'General case' 0 C--O 1.227 -0.108 0 N-CA-C 106.197 -1.779 . . . . 10.0 106.197 167.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.3 pt 1.2 70.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 127.624 2.37 . . . . 10.0 114.828 -174.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 140.66 -31.15 2.24 Favored Glycine 0 CA--C 1.525 0.669 0 O-C-N 122.088 -0.382 . . . . 10.0 113.091 -175.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -46.05 104.25 0.05 OUTLIER 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.284 1.434 . . . . 10.0 111.522 178.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -68.3 92.89 0.44 Allowed 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.12 1.368 . . . . 10.0 109.949 -178.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 6.6 p -97.25 140.14 18.26 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.205 0 CA-C-O 121.097 0.475 . . . . 10.0 109.939 174.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.49 120.51 26.4 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.949 1.3 . . . . 10.0 108.215 172.511 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.4 pp -125.13 116.68 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 N-CA-C 107.723 -1.214 . . . . 10.0 107.723 168.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 58.0 mtt -74.49 167.93 20.74 Favored 'General case' 0 C--N 1.33 -0.281 0 O-C-N 121.871 -0.518 . . . . 10.0 110.476 175.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -136.34 152.8 51.05 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 107.069 -1.456 . . . . 10.0 107.069 161.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 8.2 ttm-85 -141.97 144.37 33.67 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 124.514 1.126 . . . . 10.0 109.136 -176.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -144.12 105.7 4.28 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 127.42 2.288 . . . . 10.0 109.026 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 44.7 mttp -81.65 128.28 33.79 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 107.346 -1.353 . . . . 10.0 107.346 166.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.416 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 29.9 t30 -78.11 108.48 11.43 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-N 120.455 1.479 . . . . 10.0 110.238 174.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 71.1 mt -102.17 21.94 14.06 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.877 0.871 . . . . 10.0 112.194 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -79.39 156.05 28.12 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 108.43 -0.952 . . . . 10.0 108.43 159.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 6.1 m -98.65 19.8 14.05 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.516 0.726 . . . . 10.0 109.613 173.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 25.2 p -144.66 162.21 39.94 Favored Pre-proline 0 N--CA 1.445 -0.678 0 C-N-CA 128.198 2.599 . . . . 10.0 105.139 175.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -64.24 149.6 89.93 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 CA-C-N 119.992 1.033 . . . . 10.0 109.483 173.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -120.67 167.73 12.14 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.179 0.514 . . . . 10.0 109.93 165.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 13.2 t -94.1 169.42 10.27 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 106.812 -1.551 . . . . 10.0 106.812 158.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -148.33 148.09 19.25 Favored Glycine 0 N--CA 1.432 -1.628 0 N-CA-C 104.525 -3.43 . . . . 10.0 104.525 164.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -176.72 49.17 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 104.538 -2.393 . . . . 10.0 104.538 -163.162 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -82.82 141.13 32.53 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 115.076 -0.966 . . . . 10.0 111.115 -156.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -84.33 160.48 20.68 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 115.211 -0.904 . . . . 10.0 111.429 179.172 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -144.38 174.0 11.29 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 123.69 0.796 . . . . 10.0 111.104 176.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -127.01 106.26 9.16 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 105.001 -2.222 . . . . 10.0 105.001 159.184 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.1 t -88.65 65.82 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.251 0 CA-C-O 118.398 -0.811 . . . . 10.0 109.549 -175.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 11.2 t -174.1 147.95 1.31 Allowed Pre-proline 0 N--CA 1.464 0.248 0 CA-C-N 120.036 1.289 . . . . 10.0 111.454 178.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -64.19 -38.93 33.14 Favored 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 121.34 1.36 . . . . 10.0 110.111 159.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 9.9 ptp 174.51 -74.24 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 127.432 2.293 . . . . 10.0 107.7 179.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -73.15 -39.52 65.61 Favored 'General case' 0 C--O 1.225 -0.186 0 C-N-CA 123.34 0.656 . . . . 10.0 112.42 -172.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.73 -114.24 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.35 -0.387 . . . . 10.0 110.967 -165.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 75.04 -55.84 2.7 Favored Glycine 0 CA--C 1.526 0.742 0 O-C-N 121.527 -0.733 . . . . 10.0 112.796 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -46.43 -50.87 16.14 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 121.755 0.788 . . . . 10.0 109.694 171.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -72.81 9.37 1.15 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.13 1.772 . . . . 10.0 113.781 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.426 ' HA ' ' CD2' ' A' ' 138' ' ' LEU . 5.4 t80 -85.56 92.52 8.56 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 108.612 -0.885 . . . . 10.0 108.612 178.507 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 70.9 m-80 -82.36 79.64 8.76 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 119.893 -0.723 . . . . 10.0 110.34 -178.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.44 169.28 17.92 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.52 -0.763 . . . . 10.0 109.116 152.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 39.4 t -65.93 143.51 15.6 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 N-CA-C 109.35 -0.611 . . . . 10.0 109.35 174.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 2.1 pp0? -81.58 -157.08 0.17 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.045 0.538 . . . . 10.0 110.364 177.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 9.3 t 52.96 49.12 20.89 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.255 1.022 . . . . 10.0 112.363 176.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 73.21 -35.99 0.34 Allowed 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 116.446 2.017 . . . . 10.0 116.446 160.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . 2.327 10.0 m -60.46 16.43 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 120.929 3.677 . . . . 10.0 120.929 -139.165 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -65.93 86.1 0.09 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 121.197 1.817 . . . . 10.0 108.857 168.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 11.6 m -98.24 82.5 2.93 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.648 0.779 . . . . 10.0 110.052 -170.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -92.8 -46.71 7.41 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 108.693 -0.854 . . . . 10.0 108.693 168.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . 0.299 12.2 t 52.42 -73.6 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 128.454 2.702 . . . . 10.0 116.842 163.377 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -159.93 147.84 16.89 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 125.038 1.335 . . . . 10.0 108.804 -179.027 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 98.8 mt -146.04 149.68 34.57 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 109.211 -0.663 . . . . 10.0 109.211 172.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -88.05 162.44 40.78 Favored Pre-proline 0 CA--C 1.542 0.643 0 C-N-CA 125.298 1.439 . . . . 10.0 108.958 173.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -72.9 106.54 2.16 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 121.993 1.795 . . . . 10.0 111.272 -163.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 117.19 -6.38 17.17 Favored Glycine 0 C--N 1.336 0.567 0 C-N-CA 124.183 0.897 . . . . 10.0 111.408 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -77.45 138.75 39.44 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 118.378 1.089 . . . . 10.0 110.939 -170.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -97.9 104.18 16.19 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.391 1.076 . . . . 10.0 109.905 179.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 1.7 tmt? -81.62 133.9 35.42 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 106.049 -1.834 . . . . 10.0 106.049 165.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -148.63 148.21 29.85 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.014 -0.735 . . . . 10.0 109.014 159.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 86.4 mtp -148.33 145.2 19.88 Favored Pre-proline 0 N--CA 1.454 -0.229 0 C-N-CA 123.427 0.691 . . . . 10.0 109.219 178.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -74.03 144.33 33.88 Favored 'Trans proline' 0 N--CA 1.447 -1.258 0 C-N-CA 122.694 2.263 . . . . 10.0 109.548 163.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 37.1 t -119.13 147.57 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 N-CA-C 104.447 -2.427 . . . . 10.0 104.447 158.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 7.6 p -112.99 141.01 29.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 N-CA-C 106.627 -1.62 . . . . 10.0 106.627 167.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -145.26 147.61 32.57 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 122.668 0.387 . . . . 10.0 111.276 -164.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 21.9 p90 -156.75 169.4 24.82 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.061 0.944 . . . . 10.0 110.858 159.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 95.0 t -90.85 138.29 19.88 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 N-CA-C 107.892 -1.151 . . . . 10.0 107.892 172.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -77.54 124.98 86.66 Favored Pre-proline 0 C--O 1.233 0.214 0 CA-C-O 118.685 -0.674 . . . . 10.0 110.11 172.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -62.81 -12.36 28.64 Favored 'Trans proline' 0 N--CA 1.45 -1.045 0 C-N-CA 121.649 1.566 . . . . 10.0 112.615 172.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -56.21 -18.03 9.12 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 120.273 1.397 . . . . 10.0 112.11 166.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 13.2 tt -52.25 -43.01 38.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 O-C-N 121.026 -1.046 . . . . 10.0 111.868 166.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 14.6 m -86.04 59.45 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-N 119.443 1.019 . . . . 10.0 109.815 174.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 62.2 mttt -136.72 -66.87 0.02 OUTLIER Pre-proline 0 CA--C 1.543 0.691 0 CA-C-O 117.757 -1.116 . . . . 10.0 111.547 167.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -79.42 157.08 25.52 Favored 'Trans proline' 0 C--N 1.348 0.529 0 CA-C-N 121.862 1.701 . . . . 10.0 113.738 -166.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 85.7 t -56.05 -33.77 36.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 C-N-CA 125.257 1.423 . . . . 10.0 110.908 175.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -35.35 -57.4 0.6 Allowed 'General case' 0 C--N 1.34 0.181 0 C-N-CA 125.987 1.715 . . . . 10.0 111.934 173.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 11.1 p -102.33 -58.25 1.91 Allowed 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 114.957 -1.02 . . . . 10.0 108.598 -163.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 2.2 tp-100 24.35 49.96 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 128.951 2.901 . . . . 10.0 115.132 173.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 146.61 -37.83 1.18 Allowed Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.943 -0.863 . . . . 10.0 110.943 -168.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 21.4 mm -56.19 116.75 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 CA-C-N 117.634 0.717 . . . . 10.0 110.181 171.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 31.4 pttt -157.05 68.62 0.56 Allowed 'General case' 0 N--CA 1.443 -0.806 0 CA-C-O 121.935 0.874 . . . . 10.0 111.005 166.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 2.2 m -148.65 106.32 3.67 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 104.616 -2.364 . . . . 10.0 104.616 148.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.426 ' CD2' ' HA ' ' A' ' 95' ' ' PHE . 0.9 OUTLIER -77.88 145.97 35.91 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 107.955 -1.128 . . . . 10.0 107.955 -174.83 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 5.4 t -146.24 149.38 33.78 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 108.059 -1.089 . . . . 10.0 108.059 175.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 6.2 tt -124.17 114.45 19.66 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 102.478 -3.156 . . . . 10.0 102.478 168.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 26.9 t -87.77 107.67 18.76 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 105.992 -1.855 . . . . 10.0 105.992 172.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -102.12 128.0 48.79 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 107.084 -1.45 . . . . 10.0 107.084 -177.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 3.5 m -120.36 91.3 3.51 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.794 0.838 . . . . 10.0 110.6 -177.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -68.26 83.5 0.24 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.116 0.566 . . . . 10.0 109.809 171.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -144.85 40.99 0.29 Allowed Pre-proline 0 CA--C 1.55 0.951 0 N-CA-C 117.383 2.364 . . . . 10.0 117.383 179.13 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -73.4 -84.69 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 122.908 2.405 . . . . 10.0 113.35 -178.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 14.9 ptp180 -157.55 127.11 6.01 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 119.382 0.992 . . . . 10.0 110.308 -174.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -99.41 145.36 29.92 Favored Pre-proline 0 CA--C 1.533 0.308 0 N-CA-C 108.252 -1.018 . . . . 10.0 108.252 164.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -73.64 -59.04 0.05 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.202 0 N-CA-C 107.76 -1.669 . . . . 10.0 107.76 163.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 26.5 m -166.49 125.58 1.51 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.746 1.618 . . . . 10.0 109.252 170.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 8.2 pttt . . . . . 0 CA--C 1.543 0.682 0 C-N-CA 124.453 1.101 . . . . 10.0 111.272 161.674 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.9 p . . . . . 0 CA--C 1.533 0.293 0 N-CA-C 108.282 -1.007 . . . . 10.0 108.282 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 40.78 43.6 1.71 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.754 1.622 . . . . 10.0 111.395 -167.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 173.45 159.29 0.13 Allowed 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 131.235 3.814 . . . . 10.0 103.821 -177.199 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -157.22 24.03 0.3 Allowed 'General case' 0 C--O 1.22 -0.463 0 CA-C-N 119.021 0.828 . . . . 10.0 112.996 -166.476 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 45.9 m -75.65 3.7 9.15 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 121.034 1.743 . . . . 10.0 114.323 -169.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -77.25 -37.45 53.07 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.633 1.173 . . . . 10.0 108.892 161.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 46.6 mt -106.52 -8.71 16.93 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 127.759 2.424 . . . . 10.0 113.972 -171.309 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 92.0 mt -69.28 81.21 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 120.172 1.351 . . . . 10.0 109.214 172.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -89.29 176.05 7.1 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 107.354 -1.35 . . . . 10.0 107.354 162.155 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -76.44 -18.87 58.58 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 115.655 1.724 . . . . 10.0 115.655 -154.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -51.45 102.4 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 119.699 1.136 . . . . 10.0 112.763 -176.13 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 46.3 tttp -76.95 86.02 3.49 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 106.139 -1.801 . . . . 10.0 106.139 173.212 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -95.25 124.95 48.02 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.675 0 N-CA-C 108.261 -1.015 . . . . 10.0 108.261 -166.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 4.9 tmtt? -78.2 147.52 34.42 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.388 1.075 . . . . 10.0 108.869 -174.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 38.8 t -137.36 147.37 26.7 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.574 0 N-CA-C 107.247 -1.39 . . . . 10.0 107.247 177.413 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 86.4 m -132.75 95.4 3.58 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 125.114 1.366 . . . . 10.0 107.579 -166.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -78.83 97.06 5.81 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 124.244 1.018 . . . . 10.0 109.147 -176.138 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -85.47 84.24 7.69 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 121.708 0.766 . . . . 10.0 109.66 -173.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -79.66 127.91 32.75 Favored 'General case' 0 CA--C 1.533 0.32 0 O-C-N 121.661 -0.649 . . . . 10.0 110.716 173.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -132.44 154.96 49.35 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 125.123 1.369 . . . . 10.0 109.071 175.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.7 p -147.95 149.43 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 C-N-CA 124.311 1.044 . . . . 10.0 109.326 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -148.22 175.17 11.28 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 125.074 1.35 . . . . 10.0 108.606 174.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -33.49 -52.51 0.39 Allowed 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 126.582 1.953 . . . . 10.0 113.711 -176.166 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -47.47 -27.57 4.29 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 125.235 1.398 . . . . 10.0 114.554 -178.201 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.45 ' CD2' ' CD2' ' A' ' 47' ' ' TRP . 0.6 OUTLIER -126.91 96.84 33.83 Favored Pre-proline 0 CA--C 1.531 0.249 0 CA-C-N 118.953 1.376 . . . . 10.0 108.829 166.11 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -81.14 44.97 1.86 Allowed 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 123.627 2.884 . . . . 10.0 110.096 -175.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.45 ' CD2' ' CD2' ' A' ' 45' ' ' LEU . 44.1 m0 -114.82 141.89 47.28 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.332 1.053 . . . . 10.0 108.325 -172.027 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -77.49 80.61 3.97 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 106.415 -1.698 . . . . 10.0 106.415 -178.501 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -82.34 89.18 6.55 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 108.372 -0.973 . . . . 10.0 108.372 -175.229 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.6 m -84.81 126.9 67.11 Favored Pre-proline 0 CA--C 1.534 0.361 0 N-CA-C 109.401 -0.592 . . . . 10.0 109.401 -175.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -70.71 153.59 64.46 Favored 'Trans proline' 0 N--CA 1.448 -1.162 0 N-CA-C 107.659 -1.708 . . . . 10.0 107.659 158.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -78.96 -52.41 15.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 121.35 0.595 . . . . 10.0 109.726 178.74 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -131.14 159.57 37.27 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 104.696 -2.335 . . . . 10.0 104.696 164.115 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 32.0 tpt180 -58.99 -39.71 82.66 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 109.022 -0.733 . . . . 10.0 109.022 169.201 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.9 p30 -150.79 165.49 33.39 Favored 'General case' 0 N--CA 1.437 -1.102 0 C-N-CA 125.143 1.377 . . . . 10.0 110.718 -163.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 46.6 pt -144.63 179.33 1.33 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.178 0 C-N-CA 126.91 2.084 . . . . 10.0 107.788 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -128.52 158.69 37.7 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 108.924 -0.769 . . . . 10.0 108.924 150.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 34.6 m -133.76 141.44 44.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 C-N-CA 126.096 1.759 . . . . 10.0 107.645 173.346 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 5.5 mmm-85 -75.07 91.41 2.55 Favored 'General case' 0 C--O 1.227 -0.108 0 N-CA-C 106.197 -1.779 . . . . 10.0 106.197 167.109 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.43 HD12 ' HB3' ' A' ' 124' ' ' PRO . 6.3 pt 1.2 70.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 127.624 2.37 . . . . 10.0 114.828 -174.476 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 140.66 -31.15 2.24 Favored Glycine 0 CA--C 1.525 0.669 0 O-C-N 122.088 -0.382 . . . . 10.0 113.091 -175.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -46.05 104.25 0.05 OUTLIER 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.284 1.434 . . . . 10.0 111.522 178.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -68.3 92.89 0.44 Allowed 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.12 1.368 . . . . 10.0 109.949 -178.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 6.6 p -97.25 140.14 18.26 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.205 0 CA-C-O 121.097 0.475 . . . . 10.0 109.939 174.125 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.49 120.51 26.4 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.949 1.3 . . . . 10.0 108.215 172.511 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.4 pp -125.13 116.68 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 N-CA-C 107.723 -1.214 . . . . 10.0 107.723 168.171 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 58.0 mtt -74.49 167.93 20.74 Favored 'General case' 0 C--N 1.33 -0.281 0 O-C-N 121.871 -0.518 . . . . 10.0 110.476 175.376 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -136.34 152.8 51.05 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 107.069 -1.456 . . . . 10.0 107.069 161.165 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.41 HH12 ' CD ' ' A' ' 113' ' ' GLU . 8.2 ttm-85 -141.97 144.37 33.67 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 124.514 1.126 . . . . 10.0 109.136 -176.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -144.12 105.7 4.28 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 127.42 2.288 . . . . 10.0 109.026 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 44.7 mttp -81.65 128.28 33.79 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 107.346 -1.353 . . . . 10.0 107.346 166.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.425 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 29.9 t30 -78.11 108.48 11.43 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-N 120.455 1.479 . . . . 10.0 110.238 174.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 71.1 mt -102.17 21.94 14.06 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.877 0.871 . . . . 10.0 112.194 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -79.39 156.05 28.12 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 108.43 -0.952 . . . . 10.0 108.43 159.141 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 6.1 m -98.65 19.8 14.05 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.516 0.726 . . . . 10.0 109.613 173.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 25.2 p -144.66 162.21 39.94 Favored Pre-proline 0 N--CA 1.445 -0.678 0 C-N-CA 128.198 2.599 . . . . 10.0 105.139 175.209 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -64.24 149.6 89.93 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 CA-C-N 119.992 1.033 . . . . 10.0 109.483 173.356 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -120.67 167.73 12.14 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.179 0.514 . . . . 10.0 109.93 165.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 13.2 t -94.1 169.42 10.27 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 106.812 -1.551 . . . . 10.0 106.812 158.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -148.33 148.09 19.25 Favored Glycine 0 N--CA 1.432 -1.628 0 N-CA-C 104.525 -3.43 . . . . 10.0 104.525 164.188 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -176.72 49.17 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 104.538 -2.393 . . . . 10.0 104.538 -163.162 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -82.82 141.13 32.53 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 115.076 -0.966 . . . . 10.0 111.115 -156.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -84.33 160.48 20.68 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 115.211 -0.904 . . . . 10.0 111.429 179.172 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -144.38 174.0 11.29 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 123.69 0.796 . . . . 10.0 111.104 176.741 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -127.01 106.26 9.16 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 105.001 -2.222 . . . . 10.0 105.001 159.184 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.1 t -88.65 65.82 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.251 0 CA-C-O 118.398 -0.811 . . . . 10.0 109.549 -175.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 11.2 t -174.1 147.95 1.31 Allowed Pre-proline 0 N--CA 1.464 0.248 0 CA-C-N 120.036 1.289 . . . . 10.0 111.454 178.047 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -64.19 -38.93 33.14 Favored 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 121.34 1.36 . . . . 10.0 110.111 159.06 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 9.9 ptp 174.51 -74.24 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 127.432 2.293 . . . . 10.0 107.7 179.467 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -73.15 -39.52 65.61 Favored 'General case' 0 C--O 1.225 -0.186 0 C-N-CA 123.34 0.656 . . . . 10.0 112.42 -172.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.73 -114.24 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.35 -0.387 . . . . 10.0 110.967 -165.392 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 75.04 -55.84 2.7 Favored Glycine 0 CA--C 1.526 0.742 0 O-C-N 121.527 -0.733 . . . . 10.0 112.796 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -46.43 -50.87 16.14 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 121.755 0.788 . . . . 10.0 109.694 171.27 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -72.81 9.37 1.15 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.13 1.772 . . . . 10.0 113.781 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.458 ' HA ' ' CD2' ' A' ' 138' ' ' LEU . 5.4 t80 -85.56 92.52 8.56 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 108.612 -0.885 . . . . 10.0 108.612 178.507 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 70.9 m-80 -82.36 79.64 8.76 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 119.893 -0.723 . . . . 10.0 110.34 -178.424 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.44 169.28 17.92 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.52 -0.763 . . . . 10.0 109.116 152.489 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 39.4 t -65.93 143.51 15.6 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 N-CA-C 109.35 -0.611 . . . . 10.0 109.35 174.104 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 2.1 pp0? -81.58 -157.08 0.17 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.045 0.538 . . . . 10.0 110.364 177.295 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 9.3 t 52.96 49.12 20.89 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.255 1.022 . . . . 10.0 112.363 176.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 73.21 -35.99 0.34 Allowed 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 116.446 2.017 . . . . 10.0 116.446 160.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . 2.327 10.0 m -60.46 16.43 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 120.929 3.677 . . . . 10.0 120.929 -139.165 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -65.93 86.1 0.09 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 121.197 1.817 . . . . 10.0 108.857 168.491 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 11.6 m -98.24 82.5 2.93 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.648 0.779 . . . . 10.0 110.052 -170.318 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -92.8 -46.71 7.41 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 108.693 -0.854 . . . . 10.0 108.693 168.013 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.403 HG23 ' H ' ' A' ' 107' ' ' THR 0.299 12.2 t 52.42 -73.6 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 128.454 2.702 . . . . 10.0 116.842 163.377 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.403 ' H ' HG23 ' A' ' 106' ' ' THR . 0.4 OUTLIER -159.93 147.84 16.89 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 125.038 1.335 . . . . 10.0 108.804 -179.027 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 98.8 mt -146.04 149.68 34.57 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 109.211 -0.663 . . . . 10.0 109.211 172.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -88.05 162.44 40.78 Favored Pre-proline 0 CA--C 1.542 0.643 0 C-N-CA 125.298 1.439 . . . . 10.0 108.958 173.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -72.9 106.54 2.16 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 121.993 1.795 . . . . 10.0 111.272 -163.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 117.19 -6.38 17.17 Favored Glycine 0 C--N 1.336 0.567 0 C-N-CA 124.183 0.897 . . . . 10.0 111.408 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -77.45 138.75 39.44 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 118.378 1.089 . . . . 10.0 110.939 -170.401 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.41 ' CD ' HH12 ' A' ' 69' ' ' ARG . 33.2 mt-10 -97.9 104.18 16.19 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.391 1.076 . . . . 10.0 109.905 179.223 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 1.7 tmt? -81.62 133.9 35.42 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 106.049 -1.834 . . . . 10.0 106.049 165.092 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -148.63 148.21 29.85 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.014 -0.735 . . . . 10.0 109.014 159.389 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 86.4 mtp -148.33 145.2 19.88 Favored Pre-proline 0 N--CA 1.454 -0.229 0 C-N-CA 123.427 0.691 . . . . 10.0 109.219 178.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -74.03 144.33 33.88 Favored 'Trans proline' 0 N--CA 1.447 -1.258 0 C-N-CA 122.694 2.263 . . . . 10.0 109.548 163.159 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 37.1 t -119.13 147.57 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 N-CA-C 104.447 -2.427 . . . . 10.0 104.447 158.474 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 7.6 p -112.99 141.01 29.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 N-CA-C 106.627 -1.62 . . . . 10.0 106.627 167.272 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -145.26 147.61 32.57 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 122.668 0.387 . . . . 10.0 111.276 -164.265 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 21.9 p90 -156.75 169.4 24.82 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.061 0.944 . . . . 10.0 110.858 159.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 95.0 t -90.85 138.29 19.88 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 N-CA-C 107.892 -1.151 . . . . 10.0 107.892 172.307 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -77.54 124.98 86.66 Favored Pre-proline 0 C--O 1.233 0.214 0 CA-C-O 118.685 -0.674 . . . . 10.0 110.11 172.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.43 ' HB3' HD12 ' A' ' 60' ' ' ILE . 19.1 Cg_endo -62.81 -12.36 28.64 Favored 'Trans proline' 0 N--CA 1.45 -1.045 0 C-N-CA 121.649 1.566 . . . . 10.0 112.615 172.2 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -56.21 -18.03 9.12 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 120.273 1.397 . . . . 10.0 112.11 166.38 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 13.2 tt -52.25 -43.01 38.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 O-C-N 121.026 -1.046 . . . . 10.0 111.868 166.383 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 14.6 m -86.04 59.45 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-N 119.443 1.019 . . . . 10.0 109.815 174.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 62.2 mttt -136.72 -66.87 0.02 OUTLIER Pre-proline 0 CA--C 1.543 0.691 0 CA-C-O 117.757 -1.116 . . . . 10.0 111.547 167.582 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -79.42 157.08 25.52 Favored 'Trans proline' 0 C--N 1.348 0.529 0 CA-C-N 121.862 1.701 . . . . 10.0 113.738 -166.417 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 85.7 t -56.05 -33.77 36.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 C-N-CA 125.257 1.423 . . . . 10.0 110.908 175.221 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -35.35 -57.4 0.6 Allowed 'General case' 0 C--N 1.34 0.181 0 C-N-CA 125.987 1.715 . . . . 10.0 111.934 173.218 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 11.1 p -102.33 -58.25 1.91 Allowed 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 114.957 -1.02 . . . . 10.0 108.598 -163.468 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 2.2 tp-100 24.35 49.96 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 128.951 2.901 . . . . 10.0 115.132 173.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 146.61 -37.83 1.18 Allowed Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.943 -0.863 . . . . 10.0 110.943 -168.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 21.4 mm -56.19 116.75 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 CA-C-N 117.634 0.717 . . . . 10.0 110.181 171.446 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 31.4 pttt -157.05 68.62 0.56 Allowed 'General case' 0 N--CA 1.443 -0.806 0 CA-C-O 121.935 0.874 . . . . 10.0 111.005 166.357 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 2.2 m -148.65 106.32 3.67 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 104.616 -2.364 . . . . 10.0 104.616 148.088 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.458 ' CD2' ' HA ' ' A' ' 95' ' ' PHE . 0.9 OUTLIER -77.88 145.97 35.91 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 107.955 -1.128 . . . . 10.0 107.955 -174.83 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 5.4 t -146.24 149.38 33.78 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 108.059 -1.089 . . . . 10.0 108.059 175.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 6.2 tt -124.17 114.45 19.66 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 102.478 -3.156 . . . . 10.0 102.478 168.599 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 26.9 t -87.77 107.67 18.76 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 105.992 -1.855 . . . . 10.0 105.992 172.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -102.12 128.0 48.79 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 107.084 -1.45 . . . . 10.0 107.084 -177.641 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 3.5 m -120.36 91.3 3.51 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.794 0.838 . . . . 10.0 110.6 -177.624 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -68.26 83.5 0.24 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.116 0.566 . . . . 10.0 109.809 171.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -144.85 40.99 0.29 Allowed Pre-proline 0 CA--C 1.55 0.951 0 N-CA-C 117.383 2.364 . . . . 10.0 117.383 179.13 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.424 ' CD ' HD12 ' A' ' 45' ' ' LEU . 59.0 Cg_endo -73.4 -84.69 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 122.908 2.405 . . . . 10.0 113.35 -178.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 14.9 ptp180 -157.55 127.11 6.01 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 119.382 0.992 . . . . 10.0 110.308 -174.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -99.41 145.36 29.92 Favored Pre-proline 0 CA--C 1.533 0.308 0 N-CA-C 108.252 -1.018 . . . . 10.0 108.252 164.049 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -73.64 -59.04 0.05 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.202 0 N-CA-C 107.76 -1.669 . . . . 10.0 107.76 163.386 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 26.5 m -166.49 125.58 1.51 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.746 1.618 . . . . 10.0 109.252 170.22 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 8.2 pttt . . . . . 0 CA--C 1.543 0.682 0 C-N-CA 124.453 1.101 . . . . 10.0 111.272 161.674 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.9 p . . . . . 0 CA--C 1.533 0.293 0 N-CA-C 108.282 -1.007 . . . . 10.0 108.282 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 40.78 43.6 1.71 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.754 1.622 . . . . 10.0 111.395 -167.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 173.45 159.29 0.13 Allowed 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 131.235 3.814 . . . . 10.0 103.821 -177.199 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -157.22 24.03 0.3 Allowed 'General case' 0 C--O 1.22 -0.463 0 CA-C-N 119.021 0.828 . . . . 10.0 112.996 -166.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 45.9 m -75.65 3.7 9.15 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 121.034 1.743 . . . . 10.0 114.323 -169.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -77.25 -37.45 53.07 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.633 1.173 . . . . 10.0 108.892 161.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 46.6 mt -106.52 -8.71 16.93 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 127.759 2.424 . . . . 10.0 113.972 -171.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 92.0 mt -69.28 81.21 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 120.172 1.351 . . . . 10.0 109.214 172.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -89.29 176.05 7.1 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 107.354 -1.35 . . . . 10.0 107.354 162.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -76.44 -18.87 58.58 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 115.655 1.724 . . . . 10.0 115.655 -154.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -51.45 102.4 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 119.699 1.136 . . . . 10.0 112.763 -176.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 46.3 tttp -76.95 86.02 3.49 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 106.139 -1.801 . . . . 10.0 106.139 173.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -95.25 124.95 48.02 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.675 0 N-CA-C 108.261 -1.015 . . . . 10.0 108.261 -166.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 4.9 tmtt? -78.2 147.52 34.42 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.388 1.075 . . . . 10.0 108.869 -174.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 38.8 t -137.36 147.37 26.7 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.574 0 N-CA-C 107.247 -1.39 . . . . 10.0 107.247 177.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 86.4 m -132.75 95.4 3.58 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 125.114 1.366 . . . . 10.0 107.579 -166.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -78.83 97.06 5.81 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 124.244 1.018 . . . . 10.0 109.147 -176.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -85.47 84.24 7.69 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 121.708 0.766 . . . . 10.0 109.66 -173.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -79.66 127.91 32.75 Favored 'General case' 0 CA--C 1.533 0.32 0 O-C-N 121.661 -0.649 . . . . 10.0 110.716 173.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -132.44 154.96 49.35 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 125.123 1.369 . . . . 10.0 109.071 175.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.7 p -147.95 149.43 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 C-N-CA 124.311 1.044 . . . . 10.0 109.326 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -148.22 175.17 11.28 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 125.074 1.35 . . . . 10.0 108.606 174.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -33.49 -52.51 0.39 Allowed 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 126.582 1.953 . . . . 10.0 113.711 -176.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -47.47 -27.57 4.29 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 125.235 1.398 . . . . 10.0 114.554 -178.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.45 ' CD2' ' CD2' ' A' ' 47' ' ' TRP . 0.6 OUTLIER -126.91 96.84 33.83 Favored Pre-proline 0 CA--C 1.531 0.249 0 CA-C-N 118.953 1.376 . . . . 10.0 108.829 166.11 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -81.14 44.97 1.86 Allowed 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 123.627 2.884 . . . . 10.0 110.096 -175.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.45 ' CD2' ' CD2' ' A' ' 45' ' ' LEU . 44.1 m0 -114.82 141.89 47.28 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.332 1.053 . . . . 10.0 108.325 -172.027 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -77.49 80.61 3.97 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 106.415 -1.698 . . . . 10.0 106.415 -178.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -82.34 89.18 6.55 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 108.372 -0.973 . . . . 10.0 108.372 -175.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.6 m -84.81 126.9 67.11 Favored Pre-proline 0 CA--C 1.534 0.361 0 N-CA-C 109.401 -0.592 . . . . 10.0 109.401 -175.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -70.71 153.59 64.46 Favored 'Trans proline' 0 N--CA 1.448 -1.162 0 N-CA-C 107.659 -1.708 . . . . 10.0 107.659 158.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -78.96 -52.41 15.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 121.35 0.595 . . . . 10.0 109.726 178.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -131.14 159.57 37.27 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 104.696 -2.335 . . . . 10.0 104.696 164.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 32.0 tpt180 -58.99 -39.71 82.66 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 109.022 -0.733 . . . . 10.0 109.022 169.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.9 p30 -150.79 165.49 33.39 Favored 'General case' 0 N--CA 1.437 -1.102 0 C-N-CA 125.143 1.377 . . . . 10.0 110.718 -163.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 46.6 pt -144.63 179.33 1.33 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.178 0 C-N-CA 126.91 2.084 . . . . 10.0 107.788 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -128.52 158.69 37.7 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 108.924 -0.769 . . . . 10.0 108.924 150.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 34.6 m -133.76 141.44 44.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 C-N-CA 126.096 1.759 . . . . 10.0 107.645 173.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 5.5 mmm-85 -75.07 91.41 2.55 Favored 'General case' 0 C--O 1.227 -0.108 0 N-CA-C 106.197 -1.779 . . . . 10.0 106.197 167.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.43 HD12 ' HB3' ' A' ' 124' ' ' PRO . 6.3 pt 1.2 70.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 127.624 2.37 . . . . 10.0 114.828 -174.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 140.66 -31.15 2.24 Favored Glycine 0 CA--C 1.525 0.669 0 O-C-N 122.088 -0.382 . . . . 10.0 113.091 -175.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -46.05 104.25 0.05 OUTLIER 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.284 1.434 . . . . 10.0 111.522 178.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -68.3 92.89 0.44 Allowed 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.12 1.368 . . . . 10.0 109.949 -178.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 6.6 p -97.25 140.14 18.26 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.205 0 CA-C-O 121.097 0.475 . . . . 10.0 109.939 174.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.49 120.51 26.4 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.949 1.3 . . . . 10.0 108.215 172.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.4 pp -125.13 116.68 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 N-CA-C 107.723 -1.214 . . . . 10.0 107.723 168.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 58.0 mtt -74.49 167.93 20.74 Favored 'General case' 0 C--N 1.33 -0.281 0 O-C-N 121.871 -0.518 . . . . 10.0 110.476 175.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -136.34 152.8 51.05 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 107.069 -1.456 . . . . 10.0 107.069 161.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.41 HH12 ' CD ' ' A' ' 113' ' ' GLU . 8.2 ttm-85 -141.97 144.37 33.67 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 124.514 1.126 . . . . 10.0 109.136 -176.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -144.12 105.7 4.28 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 127.42 2.288 . . . . 10.0 109.026 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 44.7 mttp -81.65 128.28 33.79 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 107.346 -1.353 . . . . 10.0 107.346 166.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.425 ' HA ' ' CD1' ' A' ' 47' ' ' TRP . 29.9 t30 -78.11 108.48 11.43 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-N 120.455 1.479 . . . . 10.0 110.238 174.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 71.1 mt -102.17 21.94 14.06 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.877 0.871 . . . . 10.0 112.194 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -79.39 156.05 28.12 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 108.43 -0.952 . . . . 10.0 108.43 159.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 6.1 m -98.65 19.8 14.05 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.516 0.726 . . . . 10.0 109.613 173.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 25.2 p -144.66 162.21 39.94 Favored Pre-proline 0 N--CA 1.445 -0.678 0 C-N-CA 128.198 2.599 . . . . 10.0 105.139 175.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -64.24 149.6 89.93 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 CA-C-N 119.992 1.033 . . . . 10.0 109.483 173.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -120.67 167.73 12.14 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.179 0.514 . . . . 10.0 109.93 165.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 13.2 t -94.1 169.42 10.27 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 106.812 -1.551 . . . . 10.0 106.812 158.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -148.33 148.09 19.25 Favored Glycine 0 N--CA 1.432 -1.628 0 N-CA-C 104.525 -3.43 . . . . 10.0 104.525 164.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -176.72 49.17 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 104.538 -2.393 . . . . 10.0 104.538 -163.162 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -82.82 141.13 32.53 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 115.076 -0.966 . . . . 10.0 111.115 -156.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -84.33 160.48 20.68 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 115.211 -0.904 . . . . 10.0 111.429 179.172 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -144.38 174.0 11.29 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 123.69 0.796 . . . . 10.0 111.104 176.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -127.01 106.26 9.16 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 105.001 -2.222 . . . . 10.0 105.001 159.184 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.1 t -88.65 65.82 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.251 0 CA-C-O 118.398 -0.811 . . . . 10.0 109.549 -175.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 11.2 t -174.1 147.95 1.31 Allowed Pre-proline 0 N--CA 1.464 0.248 0 CA-C-N 120.036 1.289 . . . . 10.0 111.454 178.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -64.19 -38.93 33.14 Favored 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 121.34 1.36 . . . . 10.0 110.111 159.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 9.9 ptp 174.51 -74.24 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 127.432 2.293 . . . . 10.0 107.7 179.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -73.15 -39.52 65.61 Favored 'General case' 0 C--O 1.225 -0.186 0 C-N-CA 123.34 0.656 . . . . 10.0 112.42 -172.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.73 -114.24 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.35 -0.387 . . . . 10.0 110.967 -165.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 75.04 -55.84 2.7 Favored Glycine 0 CA--C 1.526 0.742 0 O-C-N 121.527 -0.733 . . . . 10.0 112.796 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -46.43 -50.87 16.14 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 121.755 0.788 . . . . 10.0 109.694 171.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -72.81 9.37 1.15 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.13 1.772 . . . . 10.0 113.781 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.458 ' HA ' ' CD2' ' A' ' 138' ' ' LEU . 5.4 t80 -85.56 92.52 8.56 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 108.612 -0.885 . . . . 10.0 108.612 178.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 70.9 m-80 -82.36 79.64 8.76 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 119.893 -0.723 . . . . 10.0 110.34 -178.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.44 169.28 17.92 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.52 -0.763 . . . . 10.0 109.116 152.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 39.4 t -65.93 143.51 15.6 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 N-CA-C 109.35 -0.611 . . . . 10.0 109.35 174.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 2.1 pp0? -81.58 -157.08 0.17 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.045 0.538 . . . . 10.0 110.364 177.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 9.3 t 52.96 49.12 20.89 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.255 1.022 . . . . 10.0 112.363 176.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 73.21 -35.99 0.34 Allowed 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 116.446 2.017 . . . . 10.0 116.446 160.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . 2.327 10.0 m -60.46 16.43 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 120.929 3.677 . . . . 10.0 120.929 -139.165 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -65.93 86.1 0.09 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 121.197 1.817 . . . . 10.0 108.857 168.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 11.6 m -98.24 82.5 2.93 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.648 0.779 . . . . 10.0 110.052 -170.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -92.8 -46.71 7.41 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 108.693 -0.854 . . . . 10.0 108.693 168.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.403 HG23 ' H ' ' A' ' 107' ' ' THR 0.299 12.2 t 52.42 -73.6 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 128.454 2.702 . . . . 10.0 116.842 163.377 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.403 ' H ' HG23 ' A' ' 106' ' ' THR . 0.4 OUTLIER -159.93 147.84 16.89 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 125.038 1.335 . . . . 10.0 108.804 -179.027 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 98.8 mt -146.04 149.68 34.57 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 109.211 -0.663 . . . . 10.0 109.211 172.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -88.05 162.44 40.78 Favored Pre-proline 0 CA--C 1.542 0.643 0 C-N-CA 125.298 1.439 . . . . 10.0 108.958 173.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -72.9 106.54 2.16 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 121.993 1.795 . . . . 10.0 111.272 -163.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 117.19 -6.38 17.17 Favored Glycine 0 C--N 1.336 0.567 0 C-N-CA 124.183 0.897 . . . . 10.0 111.408 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -77.45 138.75 39.44 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 118.378 1.089 . . . . 10.0 110.939 -170.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.41 ' CD ' HH12 ' A' ' 69' ' ' ARG . 33.2 mt-10 -97.9 104.18 16.19 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.391 1.076 . . . . 10.0 109.905 179.223 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 1.7 tmt? -81.62 133.9 35.42 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 106.049 -1.834 . . . . 10.0 106.049 165.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -148.63 148.21 29.85 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.014 -0.735 . . . . 10.0 109.014 159.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 86.4 mtp -148.33 145.2 19.88 Favored Pre-proline 0 N--CA 1.454 -0.229 0 C-N-CA 123.427 0.691 . . . . 10.0 109.219 178.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -74.03 144.33 33.88 Favored 'Trans proline' 0 N--CA 1.447 -1.258 0 C-N-CA 122.694 2.263 . . . . 10.0 109.548 163.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 37.1 t -119.13 147.57 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 N-CA-C 104.447 -2.427 . . . . 10.0 104.447 158.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 7.6 p -112.99 141.01 29.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 N-CA-C 106.627 -1.62 . . . . 10.0 106.627 167.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -145.26 147.61 32.57 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 122.668 0.387 . . . . 10.0 111.276 -164.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 21.9 p90 -156.75 169.4 24.82 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.061 0.944 . . . . 10.0 110.858 159.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 95.0 t -90.85 138.29 19.88 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 N-CA-C 107.892 -1.151 . . . . 10.0 107.892 172.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -77.54 124.98 86.66 Favored Pre-proline 0 C--O 1.233 0.214 0 CA-C-O 118.685 -0.674 . . . . 10.0 110.11 172.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.43 ' HB3' HD12 ' A' ' 60' ' ' ILE . 19.1 Cg_endo -62.81 -12.36 28.64 Favored 'Trans proline' 0 N--CA 1.45 -1.045 0 C-N-CA 121.649 1.566 . . . . 10.0 112.615 172.2 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -56.21 -18.03 9.12 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 120.273 1.397 . . . . 10.0 112.11 166.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 13.2 tt -52.25 -43.01 38.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 O-C-N 121.026 -1.046 . . . . 10.0 111.868 166.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 14.6 m -86.04 59.45 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-N 119.443 1.019 . . . . 10.0 109.815 174.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 62.2 mttt -136.72 -66.87 0.02 OUTLIER Pre-proline 0 CA--C 1.543 0.691 0 CA-C-O 117.757 -1.116 . . . . 10.0 111.547 167.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -79.42 157.08 25.52 Favored 'Trans proline' 0 C--N 1.348 0.529 0 CA-C-N 121.862 1.701 . . . . 10.0 113.738 -166.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 85.7 t -56.05 -33.77 36.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 C-N-CA 125.257 1.423 . . . . 10.0 110.908 175.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -35.35 -57.4 0.6 Allowed 'General case' 0 C--N 1.34 0.181 0 C-N-CA 125.987 1.715 . . . . 10.0 111.934 173.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 11.1 p -102.33 -58.25 1.91 Allowed 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 114.957 -1.02 . . . . 10.0 108.598 -163.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 2.2 tp-100 24.35 49.96 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 128.951 2.901 . . . . 10.0 115.132 173.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 146.61 -37.83 1.18 Allowed Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.943 -0.863 . . . . 10.0 110.943 -168.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 21.4 mm -56.19 116.75 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 CA-C-N 117.634 0.717 . . . . 10.0 110.181 171.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 31.4 pttt -157.05 68.62 0.56 Allowed 'General case' 0 N--CA 1.443 -0.806 0 CA-C-O 121.935 0.874 . . . . 10.0 111.005 166.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 2.2 m -148.65 106.32 3.67 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 104.616 -2.364 . . . . 10.0 104.616 148.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.458 ' CD2' ' HA ' ' A' ' 95' ' ' PHE . 0.9 OUTLIER -77.88 145.97 35.91 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 107.955 -1.128 . . . . 10.0 107.955 -174.83 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 5.4 t -146.24 149.38 33.78 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 108.059 -1.089 . . . . 10.0 108.059 175.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 6.2 tt -124.17 114.45 19.66 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 102.478 -3.156 . . . . 10.0 102.478 168.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 26.9 t -87.77 107.67 18.76 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 105.992 -1.855 . . . . 10.0 105.992 172.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -102.12 128.0 48.79 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 107.084 -1.45 . . . . 10.0 107.084 -177.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 3.5 m -120.36 91.3 3.51 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.794 0.838 . . . . 10.0 110.6 -177.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -68.26 83.5 0.24 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.116 0.566 . . . . 10.0 109.809 171.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -144.85 40.99 0.29 Allowed Pre-proline 0 CA--C 1.55 0.951 0 N-CA-C 117.383 2.364 . . . . 10.0 117.383 179.13 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.424 ' CD ' HD12 ' A' ' 45' ' ' LEU . 59.0 Cg_endo -73.4 -84.69 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 122.908 2.405 . . . . 10.0 113.35 -178.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 14.9 ptp180 -157.55 127.11 6.01 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 119.382 0.992 . . . . 10.0 110.308 -174.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -99.41 145.36 29.92 Favored Pre-proline 0 CA--C 1.533 0.308 0 N-CA-C 108.252 -1.018 . . . . 10.0 108.252 164.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -73.64 -59.04 0.05 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.202 0 N-CA-C 107.76 -1.669 . . . . 10.0 107.76 163.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 26.5 m -166.49 125.58 1.51 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.746 1.618 . . . . 10.0 109.252 170.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 8.2 pttt . . . . . 0 CA--C 1.543 0.682 0 C-N-CA 124.453 1.101 . . . . 10.0 111.272 161.674 . . . . . . . . 0 0 . 1 stop_ save_